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Abstract
Background: Expression of kisspeptin (protein) and Kiss1r (mRNA) was recently documented in the mouse uterus
on D4 of pregnancy (the day of embryo implantation) suggesting that the uterine-based kisspeptin (KP)/kisspeptin
receptor (KISS1R) signaling system regulates embryo implantation. Despite this important suggestion, it was never
demonstrated that the uterus actually exhibits a functional KP/KISS1R signaling system on D4 of pregnancy. Thus,
the goal of this study was to determine whether a functional KP/KISS1R signaling system exists in the mouse uterus
on D4 of pregnancy.
Findings: Since kisspeptin/KISS1R signaling triggers the phosphorylation of the mitogen-activated protein
kinases p38 and ERK1/2, through immunohistochemical analyses, we determined whether exogenously
administered kisspeptin could trigger p38 and ERK1/2 phosphorylation in the uterus on D4 of pregnancy. The
results clearly demonstrated that kisspeptin could and that its effects were mediated via KISS1R. Additionally,
the robust kisspeptin-triggered response was observed in the pregnant uterus only. Finally, it was demonstrated
that on D4 of pregnancy the Kiss1 null uterus expresses functional KISS1R molecules capable of mediating the
effects of kisspeptin.
Conclusions: These results lead us to conclude that on D4 of pregnancy, the mouse uterus expresses a
functional KP/KISS1R signaling system strengthening the possibility that this signaling system regulates embryo
implantation. These findings strengthen the rationale for determining whether such a functional system exists in
the uterus of the human female and if so, what role it might play in human pregnancy.
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Introduction
It is now well-established that hypothalamic kisspeptins
(KPs), signaling via their cognate receptor KISS1R, are po-
tent triggers of gonadotropin-releasing hormone (GnRH)
secretion and mice bearing a deletion of the gene encod-
ing KISS1R in the GnRH neuron display hypogonadotro-
pic hypogonadism and infertility [1, 2]. Therefore, the
hypothalamic-based KP/KISS1R signaling system is con-
sidered a major regulator of reproduction [3]. The KP/
KISS1R signaling system is also expressed in the female
reproductive tract and roles have been proposed in
positively regulating follicular development, ovulation,
embryo implantation and endometrial decidualization
[4–7]. Therefore, the peripheral KP/KISS1R signaling sys-
tem is considered a major regulator of reproduction [8].
We have previously reported that KP (protein) and
Kiss1r (mRNA) are highly expressed in the mouse uterus
on the day of implantation (that is, D4 after mating with
the day of mating designated D0) suggesting a role for
this signaling system in regulating embryo implantation
[4]. To test this idea further, we turned our attention to
mice bearing a global deletion of Kiss1. These mice are
infertile and it was assumed that their infertility was due
to a lack of hypothalamic KP/KISS1R signaling and the
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resulting reduction in gonadotropins, estradiol and pro-
gesterone [9]. However, despite the add-back of these
hormones embryos failed to implant in the Kiss1 null
uterus leading us to suggest that it was a lack of uterine
and not hypothalamic KP/KISS1R signaling that trig-
gered implantation failure. Despite this important sug-
gestion, we did not actually demonstrate the presence of
a functional KP/KISS1R signaling system in the uterus
on D4 of pregnancy. Such demonstration would have
greatly strengthened our suggestion.
Thus, the goal of this study was to determine whether
on D4 of pregnancy, the day of embryo implantation, a
functional KP/KISS1R signaling system exists in the
mouse uterus. It was previously reported that in various
cell types, the KP/KISS1R signaling triggers mitogen-
activated protein kinase (MAPK) phosphorylation. Spe-
cifically, it was demonstrated that KP treatment of
KISS1R-expressing cells triggers the phosphorylation of
the MAPKs p38 and ERK1/2 [10–12] but not SAPK/
JNK [10]. We therefore investigated whether exogen-
ously administered KP could trigger the phosphoryl-
ation of MAPKs in the uterus.
Findings
In the following studies 8–12 week old 129S1/SvImJ fe-
male mice were used. WT females and estradiol- and
gonadotropin-primed Kiss1 null females (as previously
described [4]) were mated to WT males (D0) and on the
morning of D4 of pregnancy, females which displayed a
copulatory plug (evidence of successful mating) were
injected with either phosphate-buffered saline (PBS,
100 μl) or KP54 (100 nmol/kg, 100 μl, Tocris Bioscience,
Minneapolis, MN, USA) intraperitoneally and 30 min
later were rapidly sacrificed. In addition to the use of
these pregnant mice, age-matched WT unmated but
cycling females were also treated with PBS or KP54 in
an identical manner. All experiments were repeated 6
independent times.
Immediately after drug or saline treatment, uteri were
removed and simultaneously processed for immunohisto-
chemistry using standard techniques [4] and 5 μm-thick
slices were simultaneously immunostained to detect
phosphorylated p38, ERK1/2 and SAPK/JNK. Care was
taken to expose the experimental and control tissue to
identical experimental conditions. Phosphorylated p38,
pERK1/2 and SAPK/JNK were assayed using the follow-
ing rabbit monoclonal antibodies: phospho-p38 (D3F9),
phospho-p44/42 (ERK1/2) (D13.14.4E) and phospho-
SAPK/JNK (81E11) (Cell Signaling, Boston, MA, USA).
Antigen-bound primary antibodies were detected with
the ImmunoCruz rabbit ABC Staining System sc-2018
(Santa Cruz Biotechnology, Inc. Dallas, TX, USA). Both
the primary and secondary detection systems were used
according to the manufacturers’ guidelines without any
adaptations.
KP triggers p38 phosphorylation in the uterine luminal
and glandular epithelia on D4 of pregnancy
Results showed that, compared to PBS-treated pregnant
mice (Fig. 1a and b), uteri from KP54-treated pregnant
mice exhibited (approximately 5-10-fold) higher levels of
phosphorylated p38 in all cells of both the luminal and
glandular epithelia (Fig. 1c, d and e). These findings were
recapitulated when uteri were removed from untreated
pregnant mice and then treated with either PBS or KP54
in vitro in the absence of any effects that KP54 might
have triggered in vivo at the level of the hypothalamus,
pituitary and ovaries (data not shown).
KP barely triggers p38 phosphorylation in the non-pregnant
uterus
When these studies were conducted in non-pregnant
mice, relative to PBS-treated mice (Fig. 1f ), uteri from
KP54-treated mice (Fig. 1g) failed to show a strong in-
crease in phosphorylated p38 in any cell type. However,
careful examination of several uteri did suggest there
was a very weak (approximately 1.2-fold greater) but
almost undetectable response in the uterine epithelium.
This suggest that KISS1R is weakly expressed in the
non-pregnant uterus and/or poorly coupled to p38 phos-
phorylation. The weak expression suggests the possibility
that basal kisspeptin signaling might also play a role in
the non-pregnant uterus or that basal expression keeps
the uterus in a primed-stated such that it allows for a
more rapid upregulation of signaling when it is required
during pregnancy.
KP triggers ERK1/2 phosphorylation in the uterine luminal
epithelium on D4 of pregnancy
When compared to PBS-treated pregnant mice (Fig. 1h),
uteri from KP54-treated pregnant mice exhibited visibly
higher levels of phosphorylated ERK1/2 in a subset of
cells within the luminal epithelium only (Fig. 1i and j).
When this study was conducted in non-pregnant mice,
relative to PBS-treated mice, uteri from KP54 treated
mice failed to show a visible increase in phosphorylated
ERK1/2 in any cell type (data not shown) again sup-
porting the idea that KISS1R is very weakly expressed
in the non-pregnant uterus and/or uncoupled to ERK1/
2 phosphorylation.
KP fails to trigger SAPK/JNK phosphorylation in the
uterus
Consistent with data obtained in KISS1R-expressing
Chinese hamster ovary cells [10], relative to PBS-treated
pregnant mice (Fig. 1k), uteri from KP54-treated pregnant
mice (Fig. 1l) failed to show an increase in phosphorylated
Fayazi et al. Reproductive Biology and Endocrinology  (2015) 13:105 Page 2 of 6
Fig. 1 (See legend on next page.)
Fayazi et al. Reproductive Biology and Endocrinology  (2015) 13:105 Page 3 of 6
(See figure on previous page.)
Fig. 1 KP54 administration to female WT mice on D4 of pregnancy triggers p38 and ERK1/2 phosphorylation but not SAPK/JNK. Phosphorylated p38
expression in the D4 pregnant uterus following PBS-treatment (a); part of the uterus shown in (a) is magnified to better reveal details on the endometrial
glands (b). Posphorylated p38 (p-p38) expression in the D4 pregnant uterus following KP54-treatment (c); parts of the uterus shown in (c) are magnified
to better reveal details on the endometrial glands and luminal epithelium (d and e). Phosphorylated p38 expression in the non-pregnant uterus following
PBS- (f) or KP54 (g) treatment. Phosphorylated ERK1/2 (pERK1/2) expression in the D4 pregnant uterus following PBS-treatment (h) or KP54-treatment
(i); part of the uterus shown in (i) is magnified to better reveal details on the luminal epithelium (j). Phosphorylated SAPK/JNK (pSAPK/pJNK) expression
in the D4 pregnant uterus following PBS-treatment (k) or KP54-treatment (l). AM: anti-mesometrial pole; LM: longitudinal muscle of the myometrium;
CM: circular muscle of the myometrium; E: endometrium; LE: luminal epithelium; GE: glandular epithelium; M: mesometrial pole; UL: uterine lumen
Fig. 2 KP signals specifically via KISS1R in the uterus on D4 of pregnancy in WT mice. Phosphorylated p38 expression in the D4 pregnant uterus
following 30 min PBS pre-treatment followed by 30 min PBS post-treatment (a); part of the uterus shown in (a) is magnified to better reveal
details on the endometrial glands (b). Phosphorylated p38 expression in the D4 pregnant uterus following 30 min PBS pre-treatment followed by
30 min KP54 post-treatment (c); part of the uterus shown in (c) is magnified to better reveal details on the endometrial glands (d). Phosphorylated
p38 expression in the D4 pregnant uterus following 30 min P234 pre-treatment followed by 30 min KP54 post-treatment (e); part of the uterus
shown in (e) is magnified to better reveal details on the endometrial glands (f). AM: anti-mesometrial pole; LM: longitudinal muscle of the
myometrium; CM: circular muscle of the myometrium; E: endometrium; LE: luminal epithelium; GE: glandular epithelium; M: mesometrial pole; UL:
uterine lumen
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SAPK/JNK in any cell type. Failure to detect evidence of
SAPK/JNK phosphorylation was not due to a loss in anti-
body quality since an aliquot of this antibody detected
phosphorylated SAPK/JNK in UV-treated human embry-
onic kidney 293 cells (data not shown).
KP triggers p38 phosphorylation in a KISS1R-specific
manner in the uterus on D4 of pregnancy
It was reported that in addition to KISS1R, KP can signal
via the NPFF1/GPR147 and NPFF2/GPR74 receptors [13].
Therefore, to determine whether the KP-triggered phos-
phorylation of p38 and ERK1/2 was KISS1R-specific the
following experiment was conducted. Eight to 12 week old
WT females were mated to WT males and on the morn-
ing of D4 of pregnancy, females were injected intraperito-
neally with either PBS (100 μl) or the KISS1R antagonist
P234 (100 nmol/kg, 100 μl, Tocris Bioscience, Minneap-
olis, MN, USA) [14]. Thirty minutes later a group of PBS-
treated females was injected with either PBS (100 μl) or
KP54 (100 nmol/kg, 100 μl) while the P234-treated group
was injected with KP54 (100 nmol/kg, 100 μl). Thirty
minutes later, mice were sacrificed and uteri were proc-
essed to assay for phosphorylated p38.
As expected, based on earlier findings (Fig. 1a-e) re-
sults revealed that relative to PBS-treated pregnant mice
(Fig. 2a and b), KP-triggered a robust increase in phos-
phorylated p38 levels in both the luminal and glandular
epithelia of pregnant uteri (Fig. 2c and d), however, this
KP-triggered increase was completely blocked when
mice were pretreated with P234 (Fig. 2e and f). Interest-
ingly, in P234 pretreated mice, phosphorylated p38 levels
were visibly lower (by approximately 2-fold) than that of
PBS only treated mice (Fig. 2e and f vs. 2a and b) sug-
gesting that on the day of implantation, endogenous KP
phosphorylates uterine p38. Based on preliminary data
(n = 2), similar observations were made with pERK1/2
levels at the luminal epithelium and again, consistent
with earlier experiments, KP54 had no effect on JNK/
SAPK phosphorylated levels both in the presence and
absence of P234 pre-treatment (n = 2) (data not shown).
The Kiss1−/− uterus remains responsive to KP
In a previous study we failed to rescue the implantation
defect through the add-back of KP to pregnant Kiss1−/−
females [4]. We speculated that this could have been
due to the inefficient delivery of the drug (which was ad-
ministered subcutaneously) to the uterus [15]. Another
possibility was that although Kiss1r mRNA was still
expressed in the Kiss1−/− uterus, this expression did not
result in the formation of functional receptor molecules
thus precluding the ability of KP to signal and rescue
the implantation defect. To test the latter possibility,
Kiss1−/− uteri on D4 of pregnancy were assayed for
phosphorylated p38 following KP54 treatment. Results
showed that relative to PBS-treated pregnant mice
(Fig. 3a), uteri from KP54-treated pregnant mice exhibited
higher levels of phosphorylated p38 in all cells of both the
luminal and glandular epithelia (Fig. 3b). Based on prelim-
inary data (n = 2), similar observations were made with
pERK1/2 levels at the luminal epithelium and again, con-
sistent with earlier experiments, KP54 had no effect on
JNK/SAPK phosphorylated levels (n = 2) (data not
shown). Together, these results confirm the presence of
functional KISS1R molecules coupled to p38 and ERK1/2
phosphorylation on D4 of pregnancy in the Kiss1−/− uterus
suggesting that failure of exogenous KP to rescue the im-
plantation defect, as reported by Calder et al. [4] was not
due to the lack of functional KISS1R molecules in the
uterus.
Conclusions
The goal of this study was to determine whether on D4 of
pregnancy, the day of embryo implantation, a functional
KP/KISS1R signaling system exists in the mouse uterus.
Our data clearly reveal that one exists and this major find-
ing further strengthens the possibility that this signaling
system regulates uterine functions in early pregnancy.
Fig. 3 KP54 administration to female Kiss1−/− mice on D4 of pregnancy triggers p38 phosphorylation. Phosphorylated p38 expression in the D4
pregnant uterus following PBS-treatment (a) or KP54-treatment (b). AM: anti-mesometrial pole; LM: longitudinal muscle of the myometrium; CM:
circular muscle of the myometrium; E: endometrium; LE: luminal epithelium; GE: glandular epithelium; M: mesometrial pole; UL: uterine lumen
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Because expression, as determined by phosphorylated p38
and ERK1/2 levels was localized to the uterine epithelia, it
is possible that KP/KISS1R signaling regulates embryo im-
plantation. For example, through p38 it might regulate the
availability (production and/or secretion) of glandular
products essential for implantation, or through both p38
and ERK1/2 might regulate embryo implantation at the
uterine epithelium. It is also possible that through para-
crine signaling, epithelial KP/KISS1R signaling prepares
stromal cells for decidualization in the event of successful
implantation [7, 16].
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